Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis.
In: GlobeNewswire, 2023-07-20
Zeitungsartikel
Zugriff:
Titel: |
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis.
|
---|---|
Zeitschrift: | GlobeNewswire, 2023-07-20 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|